Risk Assessment after ST-Segment Elevation Myocardial Infarction: Can Biomarkers Improve the Performance of Clinical Variables?
Álvaro García-OsunaJordi Sans-RosellóAndreu Ferrero-GregoriAitor Alquezar-ArbeAlessandro SionisJordi Ordóñez-LlanosPublished in: Journal of clinical medicine (2022)
GDF-15 and NT-proBNP added value to the usual risk assessment of STEMI patients.
Keyphrases
- st segment elevation myocardial infarction
- risk assessment
- percutaneous coronary intervention
- end stage renal disease
- newly diagnosed
- ejection fraction
- human health
- heavy metals
- prognostic factors
- coronary artery disease
- peritoneal dialysis
- st elevation myocardial infarction
- acute coronary syndrome
- atrial fibrillation